Related Experiment Video
Updated: May 5, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Multidrug resistance in cancer: role of ATP-dependent transporters
Michael M Gottesman1, Tito Fojo, Susan E Bates
1Laboratory of Cell Biology and Cancer Therapeutics Branch, The Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA. mgottesman@nih.gov
Abstract:
Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs--a trait known as multidrug resistance--remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.
Insights
Predicting and overcoming multidrug resistance (MDR) in cancer is crucial for improving chemotherapy effectiveness. Understanding how cancer cells evade drugs is key to developing better treatments for metastatic tumors.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Chemotherapeutics are primary treatments for metastatic tumors.
- Multidrug resistance (MDR) in cancer cells impedes chemotherapy success.
- Resistance mechanisms have been identified for most chemotherapeutic agents.
Purpose of the Study:
- To highlight the significance of multidrug resistance in cancer treatment.
- To emphasize the need for strategies to predict and circumvent drug resistance.
Main Methods:
- Review of three decades of multidrug resistance research.
- Analysis of identified cancer cell resistance mechanisms.
Main Results:
- Cancer cells can develop simultaneous resistance to multiple drugs (multidrug resistance).
- Resistance is observed against all effective chemotherapeutic agents, including novel ones.
- Numerous mechanisms contribute to cancer cells evading chemotherapy.
Conclusions:
- Circumventing multidrug resistance is essential for improving chemotherapy outcomes.
- Predicting drug resistance in cancer patients is a critical area for future research and clinical application.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:31Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Treatment Resistant Cancers
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters